TY - JOUR
T1 - H2O2 self-providing synergistic chemodynamic/photothermal therapy using graphene oxide supported zero valence iron nanoparticles
AU - Xu, Miao
AU - Li, Qin
AU - Xiang, Yi
AU - Yuan, Shanshan
AU - Wu, Yihan
AU - Zhang, Jing
AU - Liu, Jinliang
AU - Zhu, Xiaohui
AU - Zhang, Yong
PY - 2021
Y1 - 2021
N2 - Chemodynamic therapy (CDT) represents an emerging modality that treats cancer and other malignant diseases by using Fenton or Fenton-like catalysts to decompose hydrogen peroxide (H2O2) into toxic hydroxyl radicals (·OH). Despite its great promise, chemodynamic therapy is still limited by low endogenous H2O2 levels and lack of highly efficient nanocatalysts. In this study, we have developed multi-functional therapeutic nanocomposites GO-ZVI-GOx (GO = graphene oxide, ZVI = zero valence iron nanoparticles and GOx = glucose oxidase), where the GOx can catalyze the intracellular glucose and self-produce H2O2 for enhanced CDT therapy, and the GO is used as a template to avoid the aggregation of ZVI nanoparticles and also as an excellent photo-thermal converter for photothermal therapy under near-infrared (NIR) light. Our results show that this H2O2 self-generating nanoplatform can produce substantial amounts of reactive radicals under 808 nm NIR light due to the combinational effect of dual chemodynamic and photothermal therapy, which eventually leads to a significant decrease in cancer cell viability. It is believed that the methodology developed in this study enables conventional chemodynamic therapy to be efficiently improved, and holds great potential for overcoming challenges in many other H2O2-dependent cancer therapies. © 2021 The Author(s). Published by the Royal Society of Chemistry.
AB - Chemodynamic therapy (CDT) represents an emerging modality that treats cancer and other malignant diseases by using Fenton or Fenton-like catalysts to decompose hydrogen peroxide (H2O2) into toxic hydroxyl radicals (·OH). Despite its great promise, chemodynamic therapy is still limited by low endogenous H2O2 levels and lack of highly efficient nanocatalysts. In this study, we have developed multi-functional therapeutic nanocomposites GO-ZVI-GOx (GO = graphene oxide, ZVI = zero valence iron nanoparticles and GOx = glucose oxidase), where the GOx can catalyze the intracellular glucose and self-produce H2O2 for enhanced CDT therapy, and the GO is used as a template to avoid the aggregation of ZVI nanoparticles and also as an excellent photo-thermal converter for photothermal therapy under near-infrared (NIR) light. Our results show that this H2O2 self-generating nanoplatform can produce substantial amounts of reactive radicals under 808 nm NIR light due to the combinational effect of dual chemodynamic and photothermal therapy, which eventually leads to a significant decrease in cancer cell viability. It is believed that the methodology developed in this study enables conventional chemodynamic therapy to be efficiently improved, and holds great potential for overcoming challenges in many other H2O2-dependent cancer therapies. © 2021 The Author(s). Published by the Royal Society of Chemistry.
UR - http://www.scopus.com/inward/record.url?scp=85115169090&partnerID=8YFLogxK
UR - https://www.scopus.com/record/pubmetrics.uri?eid=2-s2.0-85115169090&origin=recordpage
U2 - 10.1039/d1ra04528h
DO - 10.1039/d1ra04528h
M3 - RGC 21 - Publication in refereed journal
C2 - 35478576
SN - 2046-2069
VL - 11
SP - 28973
EP - 28987
JO - RSC Advances
JF - RSC Advances
IS - 46
ER -